$HRGN
Harvard Apparatus Regenerative Technology Inc

2014 Q3 Form 10-Q Financial Statement

#000114420414049404 Filed on August 13, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2014 Q2
Revenue $2.000K $23.00K
YoY Change
Cost Of Revenue $1.000K $12.00K
YoY Change
Gross Profit $1.000K $11.00K
YoY Change
Gross Profit Margin 50.0% 47.83%
Selling, General & Admin $1.276M $1.330M
YoY Change 27.35% 62.2%
% of Gross Profit 127600.0% 12090.91%
Research & Development $1.401M $1.214M
YoY Change 32.42% -4.41%
% of Gross Profit 140100.0% 11036.36%
Depreciation & Amortization $110.0K $90.00K
YoY Change 175.0% 125.0%
% of Gross Profit 11000.0% 818.18%
Operating Expenses $2.677M $2.544M
YoY Change 29.95% 21.78%
Operating Profit -$2.676M -$2.533M
YoY Change 29.9% 21.25%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$4.000K $0.00
YoY Change
Pretax Income -$2.680M -$2.533M
YoY Change 30.1% 21.25%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.680M -$2.533M
YoY Change 30.1% 21.25%
Net Earnings / Revenue -134000.0% -11013.04%
Basic Earnings Per Share
Diluted Earnings Per Share -$6.872M -$6.487M
COMMON SHARES
Basic Shares Outstanding 7.847M shares 7.812M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q3 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.720M $10.07M
YoY Change
Cash & Equivalents $7.722M $10.07M
Short-Term Investments
Other Short-Term Assets $30.00K $360.0K
YoY Change 0.0%
Inventory $160.0K $150.0K
Prepaid Expenses $117.0K
Receivables $30.00K
Other Receivables $0.00
Total Short-Term Assets $8.058M $10.65M
YoY Change 24318.18%
LONG-TERM ASSETS
Property, Plant & Equipment $1.354M $1.038M
YoY Change 194.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.354M $1.038M
YoY Change 194.35%
TOTAL ASSETS
Total Short-Term Assets $8.058M $10.65M
Total Long-Term Assets $1.354M $1.038M
Total Assets $9.412M $11.69M
YoY Change 1809.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $254.0K $434.0K
YoY Change 101.59%
Accrued Expenses $430.0K $350.0K
YoY Change 72.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $716.0K $825.0K
YoY Change 88.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $716.0K $825.0K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $716.0K $825.0K
YoY Change 88.92%
SHAREHOLDERS EQUITY
Retained Earnings -$10.19M -$7.513M
YoY Change -45.1%
Common Stock $79.00K $78.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.696M $10.86M
YoY Change
Total Liabilities & Shareholders Equity $9.412M $11.69M
YoY Change 1820.82%

Cashflow Statement

Concept 2014 Q3 2014 Q2
OPERATING ACTIVITIES
Net Income -$2.680M -$2.533M
YoY Change 30.1% 21.25%
Depreciation, Depletion And Amortization $110.0K $90.00K
YoY Change 175.0% 125.0%
Cash From Operating Activities -$1.860M -$2.400M
YoY Change 5.08% 26.32%
INVESTING ACTIVITIES
Capital Expenditures -$530.0K -$260.0K
YoY Change 430.0% 766.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$530.0K -$260.0K
YoY Change 430.0% 766.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 60.00K 110.0K
YoY Change -96.77% -94.3%
NET CHANGE
Cash From Operating Activities -1.860M -2.400M
Cash From Investing Activities -530.0K -260.0K
Cash From Financing Activities 60.00K 110.0K
Net Change In Cash -2.330M -2.550M
YoY Change 23200.0%
FREE CASH FLOW
Cash From Operating Activities -$1.860M -$2.400M
Capital Expenditures -$530.0K -$260.0K
Free Cash Flow -$1.330M -$2.140M
YoY Change -20.36% 14.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1038000 USD
CY2014Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 USD
CY2014Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
41000 USD
CY2014Q2 us-gaap Liabilities
Liabilities
825000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
14489000 USD
CY2014Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
1038000 USD
CY2014Q2 us-gaap Assets
Assets
11687000 USD
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
434000 USD
CY2014Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
350000 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
825000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15064000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
575000 USD
CY2013Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
575000 USD
CY2013Q4 us-gaap Assets
Assets
15064000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
244000 USD
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
90000 USD
CY2013Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
161000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
495000 USD
CY2013Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 USD
CY2013Q4 us-gaap Liabilities
Liabilities
495000 USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
78000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
77000 USD
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18294000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16466000 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7513000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1974000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
10862000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
14569000 USD
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
15000000 USD
CY2013Q4 us-gaap Cash
Cash
14008000 USD
CY2013Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
22000 USD
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
421000 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11687000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
360000 USD
CY2014Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
16000 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7000 USD
CY2014Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
130000 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
31000 USD
hart Product Distribution Agreement Term
ProductDistributionAgreementTerm
P10Y
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7742080 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7742080 shares
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
248000 USD
CY2014Q2 us-gaap Revenues
Revenues
23000 USD
CY2014Q2 us-gaap Cost Of Revenue
CostOfRevenue
12000 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
11000 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1214000 USD
CY2014Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
88000 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1242000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
2544000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2533000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2533000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-2533000 USD
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7816000 shares
CY2014Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2527000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1471000 USD
us-gaap Depreciation
Depreciation
151000 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
60000 USD
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-49000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
189000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3809000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
495000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-495000 USD
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
0 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
358000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
3000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3943000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10065000 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
Harvard Apparatus Regenerative Technology, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001563665
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
HART
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7846959 shares

Files In Submission

Name View Source Status
0001144204-14-049404-index-headers.html Edgar Link pending
0001144204-14-049404-index.html Edgar Link pending
0001144204-14-049404.txt Edgar Link pending
0001144204-14-049404-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hart-20140630.xml Edgar Link completed
hart-20140630.xsd Edgar Link pending
hart-20140630_cal.xml Edgar Link unprocessable
hart-20140630_def.xml Edgar Link unprocessable
hart-20140630_lab.xml Edgar Link unprocessable
hart-20140630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v386033_10q.htm Edgar Link pending
v386033_ex31-1.htm Edgar Link pending
v386033_ex31-2.htm Edgar Link pending
v386033_ex32-1.htm Edgar Link pending
v386033_ex32-2.htm Edgar Link pending